Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients With Haemophilia A
Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Paediatric Previously Untreated Patients With Haemophilia A
This trial is conducted in Asia, Europe and North America. The purpose of the trial is to evaluate the safety and efficacy of turoctocog alfa in prevention and treatment of bleeds in previously untreated children with haemophilia A.
Inclusion Criteria:
Exclusion Criteria:
Chonqqing, Chongqing Municipality 400014, China
Shatin, New Territories, Hong Kong
Bornova-IZMIR, 35100, Turkey (Türkiye)